Document Detail

Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: A prospective observational study.
MedLine Citation:
PMID:  21937525     Owner:  NLM     Status:  Publisher    
Objective: To determine the safety and the self-reported efficacy of botulinum toxin injections for adult spasticity in current clinical practice. Design: A prospective observational study. Subjects: A total of 406 adult patients with focal spasticity received of 1136 series botulinum toxin injections at Bordeaux University Hospital from January 2007 to December 2009. Methods: Adverse events following botulinum toxin injections were reported. Their severity and the therapeutic efficacy of botulinum toxin injections were estimated with a four-point self-reporting scale (0 to 3). Latency and duration of adverse events and subjective improvement were also noted. Results: The data of 640 series of injections were analyzed. Forty-six (7.2%) adverse events were reported, of which 36 (78%) were local. There were 18 (39%) cases of local muscular weakness with an average duration of 30.0 (SD 38.2) days, and an average severity score of 1.0 (SD 0.97). Among systemic adverse events, there were 8 (17%) cases of excessive fatigue without global muscular weakness and 2 (4%) cases of transitory generalized muscular weakness. The average subjective improvement score was 1.89 (SD 0.97) and was higher for upper, than for lower, limbs (P=0.007). Conclusion: Self-reported adverse events following botulinum toxin injections in spasticity are rare, often benign and of short duration in current clinical practice. Botulinum toxin is considered effective by patients in treating spasticity of the upper and lower limbs.
François Muller; Emmanuelle Cugy; Camille Ducerf; Claire Delleci; Dominique Guehl; Pierre-Alain Joseph; Pierre Burbaud; Patrick Dehail
Related Documents :
19010195 - Utility of oral valganciclovir for cytomegalovirus prophylaxis: does it improve treatme...
6988945 - Prophylaxis with doxycycline (vibramycin) in colorectal surgery.
3118725 - Single-dose piperacillin versus cefoxitin combined with 10 percent mannitol bowel prepa...
3048935 - Cefoxitin for one day vs. ampicillin and metronidazole for three days in elective color...
18160495 - Long-term results of a hydroxyapatite-coated femoral component in total hip replacement...
19499865 - Sore throat or hoarse voice with bronchial blockers or double-lumen tubes for lung isol...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-21
Journal Detail:
Title:  Clinical rehabilitation     Volume:  -     ISSN:  1477-0873     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8802181     Medline TA:  Clin Rehabil     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
EA 4136 Université Bordeaux 2 Service MPR, CHU Pellegrin 33076- Bordeaux cedex, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Patient inclusion in goal setting during early inpatient rehabilitation after acquired brain injury.
Next Document:  The efficacy of forward head correction on nerve root function and pain in cervical spondylotic radi...